Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Mult Scler ; 8(4): 343-9, 2002 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-12166506

RESUMO

In order to define an activity profile in patients with multiple sclerosis (MS), T-cell subpopulations and proliferative responses to myelin basic protein (MBP) associated with anti-MBP antibodies, nitrotyrosine levels in serum and cerebrospinal fluid (CSF), and serum CD40L (sCD154) were simultaneously assessed in 29 consecutive and untreated MS patients. When compared to controls, patients in secondary progressive stable (SP/I), or in full remission (RR/I) stages, individuals with secondary progressive active disease (SPIA) or in acute relapse (RR/A) showed a significant decrease of CD4/CD45RA+ T cells associated with an increase of absolute numbers of CD4/45R0+ T cells (p < 0.001). In addition, in vitro-specific T-cell proliferative responses against MBP (SP/A, RR/A, SP/I: p < 0.001 versus controls) in association with augmented sCD154 serum levels (SP/A, RR/A, versus controls p < 0.001) and a significant increase of both CSF and serum levels of anti-MBP antibodies and nitrotyrosine levels (p < 0.001) were also found. Thus, the simultaneous evaluation of antibody and cell-mediated immunopathological parameters, along with the effector mediators of inflammation such as the nitric oxide products, offers a new integrative approach to characterize markers of clinical activity in MS patients, which may be used at the moment of the initial diagnosis and during an apparent recurrences of the disease to monitor therapeutic protocols and to determine whether immune-based nerve destruction mechanisms are still operating in patients with few clinical findings.


Assuntos
Biomarcadores , Esclerose Múltipla/diagnóstico , Esclerose Múltipla/imunologia , Tirosina/análogos & derivados , Adolescente , Adulto , Autoanticorpos/sangue , Autoanticorpos/líquido cefalorraquidiano , Ligante de CD40/sangue , Divisão Celular/imunologia , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Proteína Básica da Mielina/imunologia , Óxido Nítrico/metabolismo , Projetos Piloto , Estudos Prospectivos , Índice de Gravidade de Doença , Subpopulações de Linfócitos T , Tirosina/sangue , Tirosina/líquido cefalorraquidiano
2.
J Pediatr ; 99(1): 63-7, 1981 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-6788920

RESUMO

Plasma and cerebrospinal fluid amino acid values were determined in 29 infants 9 to 30 days of age with a confirmed diagnosis of phenylketonuria. Phenylalanine concentrations in plasma and cerebrospinal fluid were markedly elevated; the degree of elevation in the cerebrospinal fluid had a significant relationship to that of the plasma. The only other significant deviations in the plasma were reductions in the threonine and tyrosine values. Cerebrospinal fluid threonine, alanine, and arginine concentrations were reduced, whereas those of serine, isoleucine, and histidine were elevated. This combined deficiency and excess of amino acids in the central nervous system may have a significant effect on protein synthesis at a time in life when this synthesis and turnover is most active.


Assuntos
Aminoácidos/sangue , Doenças do Recém-Nascido/diagnóstico , Fenilcetonúrias/diagnóstico , Aminoácidos/líquido cefalorraquidiano , Humanos , Recém-Nascido , Fenilalanina/sangue , Fenilalanina/líquido cefalorraquidiano , Treonina/sangue , Treonina/líquido cefalorraquidiano , Tirosina/sangue , Tirosina/líquido cefalorraquidiano
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA